Consolidated Statements of Operations and Other Comprehensive Income - USD ($)	3 Months Ended			6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022		Jun. 30, 2023	Jun. 30, 2022
Revenue
Total Revenue	$ 19,153,848	$ 926,340		$ 20,080,784	$ 2,878,577
Operating Expenses
Cost of Sales	11,738,493	550,677		12,427,774	1,665,227
General and Administrative	2,305,859	2,029,925		4,633,244	4,521,153
Total Operating Expenses	14,044,352	2,580,602		17,061,018	6,186,380
Income (Loss) from Operations	5,109,496	(1,654,262)		3,019,766	(3,307,803)
Other Income (Expense)
Interest Income	92,388	196,639		131,666	369,039
Foreign Exchange Transaction Gain	1,150,830	2,077,709		362,528	2,485,804
Unrealized Gain (Loss) on Securities Investment	9,027,846	(407,407)		6,543,729	(1,230,648)
Unrealized Gain (Loss) on Securities Investment - Related Party	9,812,880	(6,459,968)		11,109,151	(9,535,742)
Realized Loss on Securities Investment	(10,557,229)	(2,918,668)		(10,688,542)	(6,355,451)
Gain (Loss) on Investment on Security by Equity Method	219,888	(79,670)		(48,388)	(216,050)
Loss on Consolidation of Alset Capital Acquisition Corp.	(21,657,036)			(21,657,036)
Finance Costs		(2,879)			(450,887)
Other Income (Expense)	987,531	(734,355)		1,090,538	550,538
Total Other Expense, Net	(10,922,902)	(8,328,599)		(13,156,354)	(14,383,397)
Net Loss Before Income Taxes	(5,813,406)	(9,982,861)		(10,136,588)	(17,691,200)
Income Tax Expense					(222,114)
Net Loss	(5,813,406)	(9,982,861)		(10,136,588)	(17,913,314)
Net Loss Attributable to Non-Controlling Interest	(5,556)	(995,502)		(470,852)	(2,458,669)
Net Loss Attributable to Common Stockholders	(5,807,850)	(8,987,359)		(9,665,736)	(15,454,645)
Other Comprehensive Loss, Net
Unrealized Loss on Securities Investment		(591)			(9,714)
Foreign Currency Translation Adjustment	(2,183,883)	(3,514,595)		(1,087,940)	(4,163,735)
Comprehensive Loss	(7,997,289)	(13,498,047)		(11,224,528)	(22,086,763)
Comprehensive Loss Attributable to Non-controlling Interests	(320,903)	(2,286,174)		(626,520)	(3,371,569)
Comprehensive Loss Attributable to Common Stockholders	$ (7,676,386)	$ (11,211,873)		$ (10,598,008)	$ (18,715,194)
Net Loss Per Share - Basic	$ (0.63)	$ (1.46)		$ (1.09)	$ (2.77)
Net Loss Per Share - Diluted	$ (0.63)	$ (1.46)		$ (1.09)	$ (2.77)
Weighted Average Common Shares Outstanding - Basic	9,235,119	6,144,550	[1]	8,845,250	5,586,433	[1]
Weighted Average Common Shares Outstanding - Diluted	9,235,119	6,144,550	[1]	8,845,250	5,586,433	[1]
Rental [Member]
Revenue
Total Revenue	$ 690,967	$ 403,900		$ 1,324,778	$ 636,482
Property [Member]
Revenue
Total Revenue	18,190,950	246,910		18,190,950	1,288,434
Biohealth [Member]
Revenue
Total Revenue		132,222		12,786	749,693
Digital Transformation Technology - Related Party [Member]
Revenue
Total Revenue	14,034	7,701		28,074	7,701
Other [Member]
Revenue
Total Revenue	$ 257,897	$ 135,607		$ 524,196	$ 196,267

[1] The numbers of weighted average outstanding common stock - basic and diluted were adjusted retrospectively to reflect 20-for-1 reverse stock split on December 28, 2022